Health
2 min read
New Clinical Trial Continues Trend of Studies Linking Injectafer to Severe Hypophosphatemia As Well As Associates the Drug with Bone Weakening
Once again, more clinical research is associating Injectafer (chemical compound: ferric carboxymaltose) with the dangerous and potentially life-threatening condition Severe Hypophosphatemia (Severe HPP). A new study just released in the February edition of the highly respected, peer-reviewed Journal of the American Medical Association (JAMA) reports…